This inventor holds 1 USPTO granted patent. Top assignee: University of Colorado. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations in Cancer Treatment by Daniel L Rudnicki
Introduction
Daniel L Rudnicki is an accomplished inventor based in Golden, CO (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. His work focuses on creating effective methods for the prevention and treatment of cancer.
Latest Patents
Daniel L Rudnicki holds 1 patent for his invention titled "Methods of treating cancer with doxazolidine and prodrugs thereof." This invention provides therapeutically effective compounds for the prevention and treatment of cancer. It also includes pharmaceutical compositions containing these compounds, as well as methods for using and administering them. Additionally, the invention features methods for activating a prodrug of these compounds by administering a peptide-directed targeting construct that delivers a prodrug-activating enzyme to a target activation site.
Career Highlights
Daniel is affiliated with the University of Colorado, where he continues to advance his research in cancer treatment. His work has the potential to significantly impact the medical field and improve patient outcomes.
Collaborations
Daniel has collaborated with notable colleagues, including Jordan W Nafie and Brian T Kalet, to further enhance his research efforts and develop innovative solutions in cancer therapy.
Conclusion
Daniel L Rudnicki's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work exemplifies the importance of research and collaboration in developing effective therapies for critical health challenges.